Croda International PLC (CRDA)

Industry Specialty Chemicals

This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

3,120.00p

Buy

3,123.00p

arrow-down-37.00p (-1.18%)

Croda International PLC is engaged in manufacturing specialty chemical. It supplies specialty ingredients for the personal care industry, pharmaceutical and nutritional markets. It also sells coating and polymer, and adhesives.
Prices updated at 16 May 2025, 16:37 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Sector
Basic Materials
Industry
Specialty Chemicals
Chairman
Ms. Danuta Gray
CEO
Mr. Stephen Edwards Foots
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
6,027
Head office
Cowick Hall
Goole
United Kingdom
DN14 9AA
mobile
+44 1405860551
letter
enquiries@linkgroup.co.uk

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Jacqueline Patricia Christine Ferguson
Non-Executive Director, Senior Independent Director
---0.10m-
Ms. Danuta Gray
Non-Executive Director, Chairman
-----
Mr. Ian Alan Bull
Non-Executive Director
---0.04m-
Mr. Keith Layden
Non-Executive Director
---0.07m-
Ms. Julie Kim
Non-Executive Director
-----
Mr. Stephen Oxley
Executive Director, Chief Financial Officer
-----
Mr. Stephen Edwards Foots
Executive Director, Chief Executive Officer
-----
Mr. Thomas Michael Brophy
Company Secretary & General Council
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Massachusetts Financial Services Company6,021,71111.911151075178-30 Apr 20254.31
Vanguard Group Inc4,125,5800.37484164667-30 Apr 20252.96
MFS Investment Management2,915,9812.61722170215-30 Apr 20252.09
BlackRock Fund Advisors2,613,3363.3822145008-30 Apr 20251.87
Vanguard2,506,3920.86231-67776-30 Apr 20251.80

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
12 May 2025PurchaseMr. Stephen Edwards Foots3196.00160249,0200.18Partnership
12 May 2025Transfer inMr. Stephen Edwards Foots--249,0250.18Matching
06 May 2025PurchaseMr. Ian Alan Bull3010.5130,1053,0000.00-
10 Apr 2025PurchaseMs. Danuta Gray2572.6314,1492,6000.00ISA
10 Apr 2025PurchaseMr. Stephen Edwards Foots2676.00134249,0100.18Partnership
10 Apr 2025Transfer inMr. Stephen Edwards Foots--249,0150.18Matching
31 Mar 2025PurchaseMs. Jacqueline Patricia Christine Ferguson2881.634,4672310.00-
24 Mar 2025Sale of OptionMr. Stephen Edwards Foots2908.5627,835251,2970.18-
24 Mar 2025Exercise of OptionMr. Stephen Edwards Foots--247,3950.18As advised by the company
24 Mar 2025Exercise of OptionMr. Stephen Edwards Foots--252,2540.18As advised by the company
24 Mar 2025Sale of OptionMr. Stephen Edwards Foots2908.5666,664249,0050.18-
10 Mar 2025Transfer inMr. Stephen Edwards Foots--245,3660.18Matching
10 Mar 2025PurchaseMr. Stephen Edwards Foots3203.00160245,3610.18Partnership
25 Feb 2025PurchaseMr. Ian Alan Bull3240.1812,9612,0000.00-
10 Feb 2025PurchaseMr. Stephen Edwards Foots3094.00155245,3510.18Partnership
10 Feb 2025Transfer inMr. Stephen Edwards Foots--245,3560.18Matching
10 Jan 2025PurchaseMr. Stephen Edwards Foots3272.00164245,3410.18Partnership
10 Jan 2025Transfer inMr. Stephen Edwards Foots--245,3460.18Matching
10 Dec 2024PurchaseMs. Danuta Gray3486.0020,0451,1500.00-
10 Dec 2024PurchaseMs. Danuta Gray3486.0020,0455750.00-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.